# OnCo record kyoto-university-hospital (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/kyoto-university-hospital/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "kyoto-university-hospital" ;
  schema:name "Kyoto University Hospital"@en ;
  schema:alternateName "京都大学医学部附属病院"@en, "Kyoto University Cancer Center"@en ;
  schema:description "The university where Tasuku Honjo discovered PD-1 and Shinya Yamanaka created iPS cells; its hospital leads Japanese immunotherapy and cell therapy research."@en ;
  schema:url <https://onco.cc/institutions/kyoto-university-hospital/>, <https://www.kuhp.kyoto-u.ac.jp> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.kuhp.kyoto-u.ac.jp>, <https://www.cira.kyoto-u.ac.jp>, <https://www.med.kyoto-u.ac.jp> ;
  schema:addressCountry "JP" ;
  schema:addressLocality "Kyoto" ;
  schema:latitude "35.02"^^xsd:decimal ;
  schema:longitude "135.775"^^xsd:decimal ;
  onco:related <https://onco.cc/collections/jsmo-jsco-guidelines/> ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-nk-macrophage/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:companies <https://onco.cc/companies/jcog/> ;
  onco:people <https://onco.cc/people/akifumi-takaori/> .